Session Details

[28-51-pm1]Social Pharmacy 1, Regulatory sciences

Sat. Mar 28, 2026 1:10 PM - 3:10 PM JST
Sat. Mar 28, 2026 4:10 AM - 6:10 AM UTC
Room 51 (B303, Bldg. 1, Area 2 [3F])
Discusser: Niioka Takenori, Miwako Kamei

[28-51-pm1-01S]Meta-analysis for the combined therapy with Sansoninto and Western medicines for insomnia

○Linfeng Liu1, Kaori Ambe1,2, Toshiaki Makino1 (1. Grad. Sch. Pharm. Sci., Nagoya City University, 2. Grad. Sch. Data Sci., Nagoya City University)

[28-51-pm1-02S]Recent trends in post-marketing surveillance under the revised GPSP ordinance

○Yui Uraki1, Saki Aino1, Mamoru Narukawa1 (1. Pharm., Kitasato Univ.)

[28-51-pm1-03S]Analysis of Sample Size Allocation to Japan and Primary Endpoint in Confirmatory Multiregional Clinical Trials

○Ayumi Hasegawa1, Shoji Sera1,2, Naomi Nagai1,2 (1. Lab. Reg. Sci., Fac. Pharm., Musashino Univ., 2. Res. Inst. Pharm. Sci., Musashino Univ.)

[28-51-pm1-04S]Probability of success in phase III trials by cancer type

○Aya Iwase1, Keiko Yamamoto1, Hideki Maeda1 (1. Meiji Pharmaceutical Univ.)

[28-51-pm1-05S]1. Development of Receptor Sensitivity Prediction Models Using Receptor Databases and Their Integration With an Adverse Event Database

○Hirokazu Mizoguchi1, Ryuichiro Hosoya1,2, Tomoko Terajima1, Yoshihiro Uesawa2, Hajime Kagaya1 (1. Shonan Univ. Medical Sci., 2. Meiji Pharmaceutical Univ.)

[28-51-pm1-06S]Evaluation of raman and fluorescence spectroscopy for discrimination of substandard and falsified medicines targeting Forxiga

○Tsukine Otogawa1, Naoko Yoshida1 (1. Grad. Sch. Pharm. Sci., Kanazawa Univ.)

[28-51-pm1-07S]Evaluation of raman and fluorescence spectroscopy in the analysis of Semaglutide injection, a GLP-1 receptor agonist

○Kana Nakajima1, Naoko Yoshida1 (1. Grad. Sch. Pharm. Sci., Kanazawa Univ.)

[28-51-pm1-08]Factors Influencing Privacy Awareness Among Patients Using Community Pharmacies

○Kaito Mori1, Toshinari Mitsuoka1 (1. Faculty of Pharmaceutical Sciences, Hokkaido University of Science)

[28-51-pm1-09]A Study on the relationship between inventory issues and prescription inquiries in community pharmacies

○Takeshi Oshizaka1, Carmen Saito1, Tomoya Sakurada1, Akiko Korikawa1, Tomoya Hasegawa2, Kazuma Kato2, Kenji Mori1, Eriko Kobayashi1, Nobunori Satoh1,2,3 (1. Faculty of Pharm. Sci., Josai International Univ., 2. JCHO Chiba Hospital, 3. Faculty of Pharm. Sci., Chiba Univ.)

[28-51-pm1-10]Contraindications, dosage adjustments, and pharmacokinetic characteristics using the Child-Pugh classification: A cross-sectional analysis of Japanese drug labeling

○Masahiro Kobayashi1,3, Moeka Ogawa2, Tatsuya Okuwaki3, Mika Maeda1,3, Katsuya Otori1,3 (1. Sch. Pharm., Kitasato Univ., 2. Grad. Sch. Pharm., Kitasato Univ., 3. Pharm. Dept., Kitasato Univ. Hosp.)